Your browser doesn't support javascript.
loading
Loss of H3K9 trimethylation leads to premature aging.
Mrabti, Calida; Yang, Na; Desdín-Micó, Gabriela; Alonso-Calleja, Alejandro; Vílchez-Acosta, Alba; Pico, Sara; Parras, Alberto; Piao, Yulan; Schoenfeldt, Lucas; Luo, Siyuan; Haghani, Amin; Brooke, Robert; Del Carmen Maza, María; Branchina, Clémence; Maroun, Céline Yacoub; von Meyenn, Ferdinand; Naveiras, Olaia; Horvath, Steve; Sen, Payel; Ocampo, Alejandro.
Afiliación
  • Mrabti C; Department of Biomedical Sciences, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Vaud, Switzerland.
  • Yang N; Laboratory of Genetics and Genomics, National Institute on Aging, NIH, Baltimore, MD 21224, USA.
  • Desdín-Micó G; Department of Biomedical Sciences, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Vaud, Switzerland.
  • Alonso-Calleja A; Laboratory of Regenerative Hematopoiesis, Department of Biomedical Sciences, University of Lausanne, Switzerland.
  • Vílchez-Acosta A; Laboratory of Metabolic Signaling, Institute of Bioengineering, Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.
  • Pico S; Department of Biomedical Sciences, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Vaud, Switzerland.
  • Parras A; Department of Biomedical Sciences, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Vaud, Switzerland.
  • Piao Y; EPITERNA SA, Epalinges, Switzerland.
  • Schoenfeldt L; Laboratory of Genetics and Genomics, National Institute on Aging, NIH, Baltimore, MD 21224, USA.
  • Luo S; Department of Biomedical Sciences, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Vaud, Switzerland.
  • Haghani A; EPITERNA SA, Epalinges, Switzerland.
  • Brooke R; Departement of Health Sciences and Technology, ETH Zurich, Zurich.
  • Del Carmen Maza M; Altos Labs, San Diego, CA, USA.
  • Branchina C; Epigenetic Clock Development, Foundation, Torrance, California, USA.
  • Maroun CY; Department of Biomedical Sciences, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Vaud, Switzerland.
  • von Meyenn F; Department of Biomedical Sciences, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Vaud, Switzerland.
  • Naveiras O; Department of Biomedical Sciences, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Vaud, Switzerland.
  • Horvath S; Departement of Health Sciences and Technology, ETH Zurich, Zurich.
  • Sen P; Laboratory of Genetics and Genomics, National Institute on Aging, NIH, Baltimore, MD 21224, USA.
  • Ocampo A; Laboratory of Regenerative Hematopoiesis, Department of Biomedical Sciences, University of Lausanne, Switzerland.
bioRxiv ; 2024 Jul 24.
Article en En | MEDLINE | ID: mdl-39091811
ABSTRACT
Aging is the major risk factor for most human diseases and represents a major socio-economical challenge for modern societies. Despite its importance, the process of aging remains poorly understood. Epigenetic dysregulation has been proposed as a key driver of the aging process. Modifications in transcriptional networks and chromatin structure might be central to age-related functional decline. A prevalent feature described during aging is the overall reduction in heterochromatin, specifically marked by the loss of repressive histone modification, Histone 3 lysine 9 trimethylation (H3K9me3). However, the role of H3K9me3 in aging, especially in mammals, remains unclear. Here we show using a novel mouse strain, (TKOc), carrying a triple knockout of three methyltransferases responsible for H3K9me3 deposition, that the inducible loss of H3K9me3 in adulthood results in premature aging. TKOc mice exhibit reduced lifespan, lower body weight, increased frailty index, multi-organ degeneration, transcriptional changes with significant upregulation of transposable elements, and accelerated epigenetic age. Our data strongly supports the concept that the loss of epigenetic information directly drives the aging process. These findings reveal the importance of epigenetic regulation in aging and suggest that interventions targeting epigenetic modifications could potentially slow down or reverse age-related decline. Understanding the molecular mechanisms underlying the process of aging will be crucial for developing novel therapeutic strategies that can delay the onset of age-associated diseases and preserve human health at old age specially in rapidly aging societies.
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: BioRxiv Año: 2024 Tipo del documento: Article País de afiliación: Suiza

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: BioRxiv Año: 2024 Tipo del documento: Article País de afiliación: Suiza